BRPI1010948A2 - Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais. - Google Patents

Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais.

Info

Publication number
BRPI1010948A2
BRPI1010948A2 BRPI1010948-0A BRPI1010948A BRPI1010948A2 BR PI1010948 A2 BRPI1010948 A2 BR PI1010948A2 BR PI1010948 A BRPI1010948 A BR PI1010948A BR PI1010948 A2 BRPI1010948 A2 BR PI1010948A2
Authority
BR
Brazil
Prior art keywords
treatment
trans
cinamaldehyde
bacterial infections
respective use
Prior art date
Application number
BRPI1010948-0A
Other languages
English (en)
Inventor
Tesse Nicolas
Original Assignee
Septeos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Septeos filed Critical Septeos
Publication of BRPI1010948A2 publication Critical patent/BRPI1010948A2/pt
Publication of BRPI1010948B1 publication Critical patent/BRPI1010948B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Medical Uses (AREA)
BRPI1010948A 2009-06-05 2010-06-07 composição antibacteriana, composição farmacêutica ou medicamento, usos da composição e processo in vitro para o preparo de uma superfície BRPI1010948B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0953734A FR2946255B1 (fr) 2009-06-05 2009-06-05 Composition comprenant du trans-cinnamaldehyde
FR0953734 2009-06-05
PCT/EP2010/057905 WO2010139805A1 (fr) 2009-06-05 2010-06-07 Composition comprenant au moins du trans- cinnamaldehyde et son utilisation dans le traitement des infections bacteriennes plus particulierement dans le traitement des maladies nosocomiales

Publications (2)

Publication Number Publication Date
BRPI1010948A2 true BRPI1010948A2 (pt) 2018-03-13
BRPI1010948B1 BRPI1010948B1 (pt) 2020-04-07

Family

ID=41264127

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010948A BRPI1010948B1 (pt) 2009-06-05 2010-06-07 composição antibacteriana, composição farmacêutica ou medicamento, usos da composição e processo in vitro para o preparo de uma superfície

Country Status (6)

Country Link
US (1) US9034918B2 (pt)
EP (1) EP2437737B1 (pt)
JP (1) JP5940446B2 (pt)
BR (1) BRPI1010948B1 (pt)
FR (1) FR2946255B1 (pt)
WO (1) WO2010139805A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2966732B1 (fr) * 2010-10-29 2013-06-28 Frederic Pierron Utilisation de l'acide cinnamique pour prevenir ou traiter des infections provoquees par un antigene resistant ou une combinaison d'antigenes
BR112013014189A8 (pt) 2010-12-09 2018-01-09 Septeos composição farmacêutica, uso de um agente de potencialização e uso de uma composição
EP2648704B1 (en) 2010-12-09 2019-01-16 Septeos Anti-microbial composition
JP5953608B2 (ja) * 2012-05-25 2016-07-20 日本ゼトック株式会社 バイオフィルム抑制剤
CN102854278A (zh) * 2012-09-11 2013-01-02 鹰潭华宝香精香料有限公司 香精香料中香豆素和黄樟素含量的测定方法
CN103212112B (zh) * 2013-05-06 2015-10-07 中国热带农业科学院南亚热带作物研究所 一种含有天然肉桂醛抗菌消炎润滑型导尿管及其制备方法
FR3008705A1 (fr) * 2013-07-18 2015-01-23 Meto & Co Revetements composites de cuivre oxyde et/ou phosphore
FR3021218A1 (fr) * 2014-05-26 2015-11-27 Eydo Pharma Utilisation du cinnamaldehyde en association avec de l'eugenol et/ou du carvacrol pour lutter contre la resistance aux antibiotiques
KR102195307B1 (ko) * 2016-06-30 2020-12-28 더 홍콩 유니버시티 오브 사이언스 앤드 테크놀러지 표면에 대한 콜로이드성 항균 및 항-생물부착 코팅
US11266610B2 (en) * 2018-10-24 2022-03-08 Pacific University Cinnamaldehyde derivative compounds, and methods of use for cinnamaldehyde derivative compounds nicotine cessation
WO2021077016A1 (en) * 2019-10-17 2021-04-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Formulations for treatment of vibrio infections
EP4092126A1 (en) 2021-03-29 2022-11-23 Instytut Katalizy I Fizykochemii Powierzchni Im.Jerzego Habera Polskiej Akademii Nauk A method of enzymatic reduction of the oxidized nicotinamide adenine dinucleotide and carboxylic acids
CN114533780B (zh) * 2021-04-13 2023-04-07 海南启星生物科技有限公司 肉桂精油在制备抑菌药物中的用途
FR3149501A1 (fr) * 2023-06-08 2024-12-13 Wound Healing Composition a base d’huile essentielle de c. cassia et utilisations de celle-ci

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477361A (en) * 1983-02-22 1984-10-16 Sperti Drug Products, Inc. Antifungal-antibacterial detergents containing cinnamic compounds
JPH0820510A (ja) * 1994-07-06 1996-01-23 Kaneka San Supaisu:Kk 抗菌活性のある香辛料、およびこれを原料とする抗菌剤
JPH0827017A (ja) * 1994-07-18 1996-01-30 Dimotech Ltd ヘリコバクター・ピロリの成長阻害用薬剤組成物
AU1326201A (en) * 1999-07-23 2001-02-13 Libra Digital, Llc Electronic recording, analysis, editing, and playback of scents
AU2002227913B2 (en) * 2000-11-09 2007-08-02 Jorg P. Schur Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
JP2002256300A (ja) * 2001-03-02 2002-09-11 Lion Corp 液体洗浄剤組成物
CA2596049A1 (en) * 2005-01-26 2006-08-03 Emma Kvitnitsky Compositions and methods for protection of harvested fruits from decay
US20070292540A1 (en) * 2006-03-23 2007-12-20 Gow Robert T Extracts and Methods Comprising Cinnamon Species
FR2918571B1 (fr) * 2007-07-10 2013-01-11 Aroma Tech Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
US20090258098A1 (en) * 2008-04-15 2009-10-15 Lane Rolling Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections

Also Published As

Publication number Publication date
FR2946255A1 (fr) 2010-12-10
JP5940446B2 (ja) 2016-06-29
JP2012528835A (ja) 2012-11-15
US20120077875A1 (en) 2012-03-29
WO2010139805A1 (fr) 2010-12-09
FR2946255B1 (fr) 2013-05-24
BRPI1010948B1 (pt) 2020-04-07
EP2437737A1 (fr) 2012-04-11
EP2437737B1 (fr) 2018-08-29
US9034918B2 (en) 2015-05-19

Similar Documents

Publication Publication Date Title
BRPI1010948A2 (pt) Composição compreendendo pelo menos trans- cinamaldeído e a respectiva utilização no tratamento das infecções bacterianas, mais particularmente no tratamento das doenças nosocomiais.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX336260B (es) Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
BRPI0820162A2 (pt) composto, composição farmacêutica, método para a profilazia ou tratamento de infecção pela hiv ou para a profilaxia, tratamento ou retardo no início da aids
UA110199C2 (xx) Тверда дисперсія рифаксиміну
IL211120A (en) Compound, tetracycline converted at position 7c with fluorine, a pharmaceutical preparation containing it and its use in the preparation of drugs for the treatment of bacteria-caused infection
BRPI0920605A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para o tratamento ou profilaxia de infecção pelo hiv ou para o tratamento, profilaxia, ou retardo no início ou progressão da aids em um paciente em necessidade deste.
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
CL2014001154A1 (es) Compuestos derivados antibioticos de 2-oxo-oxazolidin-3,5-diilo de formula i; composicion farmaceutica; uso para la prevencion o tratamiento de una infeccion bacteriana.
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
HK1243951A1 (zh) 抗微生物组合和其在治疗微生物感染中的用途
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
UA113151C2 (xx) Застосування композиції, що містить антимікробний поліпептид, у виробництві лікарського засобу
WO2013073998A3 (ru) Новые производные гемина с антибактериальной и противовирусной активностью
EP2344642B8 (en) Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
UA95630C2 (ru) Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
WO2017158616A8 (en) Carbapenem compounds
WO2009047788A3 (en) Topical composition containing the combination of mupirocin and beclomethasone
EP2740479A4 (en) COMPOSITION WITH ANTIBIOTICS AND LYSOPHOSPHATIDYLCHOLIN TO INCREASE IMMUNITY AGAINST TREATMENT OF BACTERIAL INFECTIONS
CL2015000659A1 (es) Compuestos derivados de macrólidos; proceso de preparación; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de infecciones bacterianas.
WO2011046905A3 (en) Pharmaceutical compositions
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections
WO2009124723A3 (en) Novel aureothin derivatives

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/06/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2830 DE 01-04-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.